CNGA3 Gene Therapy Study
Produktkategorien:
At the Centre for Ophthalmology, University Hospital Tübingen, gene therapy in achromatopsia is investigated. After a phase 1 trial has proven safety and efficacy in adults, now children will also be treated. Further information:
https://www.achromatopsie.de/achromatopsie/gibt-es-eine-therapie/
